GMO Research Inc
(OTCGM:GMORF)
Open-Close-
Vol / Avg.0 / 15.000Mkt Cap0
Day Range- - -52 Wk Range- - -

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%

GMO Research Stock (OTC:GMORF), Key Statistics

GMO Research Stock (OTC: GMORF) analysis, key statistics.

Valuation Measures
Enterprise Value
25.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
973M
Total Assets
2.9B
Total Liabilities
973M
Profitability
Net income Growth
-0.73
Gross Margin
45.24%
Net Margin
1.65%
EBIT Margin
2.52%
EBITDA Margin
2.52%
Operating Margin
0.52%